Laylay, Winde .

HRN: 01-78-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
CEFUROXIME 500MG (TAB)
01/04/2026
01/11/2026
PO
500mg
BID
S/p Nsvd
Waiting Final Action 
01/07/2026
CEFUROXIME 500MG (TAB)
01/07/2026
01/14/2026
PO
1 Tab
Q8h
UTI
Waiting Final Action 
01/07/2026
CEFUROXIME 500MG (TAB)
01/07/2026
01/14/2026
PO
1 Tab
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: